# OnCo record crossfire (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/crossfire/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "crossfire", "NCT02791503" ;
  schema:name "CROSSFIRE"@en ;
  schema:alternateName "CROSSFIRE trial"@en ;
  schema:description "CROSSFIRE is the only randomised comparison of the two local treatments offered after chemotherapy for pancreatic cancer that cannot be removed, MR-guided stereotactic radiotherapy and irreversible electroporation; survival was 16.1 against 12.5 months with no significant difference, the trial stopped early for futility, and neither has been shown to beat chemotherapy alone."@en ;
  schema:url <https://onco.cc/trials/crossfire/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02791503>, <https://doi.org/10.1016/S2468-1253(24)00017-7> ;
  onco:status "negative" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/locally-advanced-pdac/> ;
  onco:technologies <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/mr-linac/>, <https://onco.cc/technologies/irreversible-electroporation/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/> ;
  onco:terms <https://onco.cc/terms/acute-cholangitis/> .